0001683168-17-000606.txt : 20170320 0001683168-17-000606.hdr.sgml : 20170320 20170320082300 ACCESSION NUMBER: 0001683168-17-000606 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170317 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170320 DATE AS OF CHANGE: 20170320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chineseinvestors.com, Inc. CENTRAL INDEX KEY: 0001459482 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-EDUCATIONAL SERVICES [8200] IRS NUMBER: 352089868 STATE OF INCORPORATION: IN FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54207 FILM NUMBER: 17700108 BUSINESS ADDRESS: STREET 1: 3810 DURBIN STREET CITY: IRWINDALE STATE: CA ZIP: 91706 BUSINESS PHONE: (303) 481-4416 MAIL ADDRESS: STREET 1: 3810 DURBIN STREET CITY: IRWINDALE STATE: CA ZIP: 91706 8-K 1 chineseinvest_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):

March 17, 2017

____________________________

 

ChineseInvestors.com, Inc.

(Exact name of registrant as specified in its charter)

____________________________

 

Indiana 000-54207   35-2089868
(State of Organization)   (Commission File Number)   (I.R.S. Employer Identification Number)

 

 

227 W. Valley Blvd. #208A, San Gabriel, CA   91776
(Address of principal executive offices)   (Zip Code)

 

(800) 808-8760

(Registrant’s telephone number, including area code)

 

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfying the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 1 
 

 

Item 8.01 - Other Events

 

ChineseInvestors.com,, Inc. has issued a new press release describing highlights of its continuing business activities in development and branding of hemp-based cannabidiol (CBD) oil online and retail sales operations world-wide and development of and investment in sales of hemp-based products in China.

 

 

Item 9.01 - Exhibits

 

Exhibit 99.1

 

99.1           Press Release dated March 17, 2017.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Date: March 20, 2017

 

ChineseInvestors.com, Inc.

 

 

 

By: /s/ Wei Wang                                               

Name: Wei Wang

Title: Chief Executive Officer

 

 

 

 

 

 

 2 

 

EX-99.1 2 chinese_ex9901.htm PRESS RELEASE

Exhibit 99.1

 

ChineseInvestors.com Launches XiBiDi Biotechnology to Reach China’s 1.4B Consumer Base

 

SAN GABRIEL, CA (March 17, 2017) - ChineseInvestors.com (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announces that it has established and registered XiBiDi Biotechnology Co., Ltd. in the Pudong Free-Trade Area in Shanghai, with registered capital requirements of $1.45 million USD over the next 10 years. XiBiDi Biotechnology will focus on the online and offline sales of health products including hemp-derived CBD (cannabidiol) oil, as well as hemp-based food and beverages. Notably, the Chinese character “XiBiDi” is homophonic to “CBD” in English.

 

“I am delighted about the establishment and registration of our new hemp company,” says CIIX founder and CEO Warren Wang. “XiBiDi Biotechnology is strategically located in the Pudong Free-Trade Area of Shanghai, China, where we have the opportunity to reach a consumer base of nearly 1.4 billion people. We believe that this large population affords XiBiDi an outstanding opportunity to be the provider of choice for natural hemp products.”

 

XiBiDi Biotechnology will be the operator of CIIX’s recently launched CBD online store, www.ChineseCBDoil.com, which will primarily focus on selling, where legal, hemp-based CBD nutrient and health products to Chinese-speaking customers worldwide through the online retail process. CIIX is also in preparations to open a retail store based in the predominantly Chinese community of San Gabriel, California.

 

The establishment of XiBiDi Biotechnology supplements these ventures as well as the Company’s broader mission to develop its presence in the hemp industry. In addition to retail and direct sales, the Company will focus on the legal import of hemp-based (but not CBD oil products) health products in China – a population increasingly interested in the health benefits of hemp and CBD oil - and the export of hemp food and beverages to the United States, Canada and Europe.

 

“As the aging population in China increases, Chinese people are paying more attention to their health; thus, we believe that the development of the health industry has a very bright future. CIIX is very excited to be the world’s first U. S. publicly traded company promoting hemp-based CBD health products and hemp foods that will help Chinese people improve their overall health. In addition, being located in the Pudong Free-Trade Area provides great convenience for the company’s future import and export business as China enacts various measures to support the development of the Pudong Free-Trade Area,” concludes Wang.

 

XiBiDi Biotechnology is registered as a wholly foreign enterprise, and the registration is expected to be completed by the end of March.

 

About ChineseInvestors.com (OTCQB: CIIX)

 

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based CBD health products via its new website: www.ChineseCBDoil.com

 

 

 

 

 

 

 

 

 1 
 

 

For more information visit www.ChineseInvestors.com

 

Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom

 

Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh

 

Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom

 

Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn.

 

Forward Looking Statement

 

Our discussion may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. Throughout today’s discussion, we will attempt to present some important factors relating to our business that may affect our predictions. You should also review our most recent Form 10-K and Form 10-Q for a more complete discussion of these factors and other risks, particularly under the heading “Risk Factors.”

 

Contact:

 

ChineseInvestors.com, Inc.

227 W. Valley Blvd, #208 A,

San Gabriel, CA 91776

 

Investor Relations:

 

Alan Klitenic

+1.214.636.2548

 

Corporate Communications:

 

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkNewsWire.com

 

 

 

 2